In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.

Romano A, Buccheri R, Zagni C, Rescifina A

Open source

DOI
10.1111/cbdd.70354
Published
2026 Jul
Container
Chemical biology & drug design
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cbdd.70354,
  title = {In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.},
  author = {Romano A and Buccheri R and Zagni C and Rescifina A},
  year = {2026},
  journal = {Chemical biology \& drug design},
  doi = {10.1111/cbdd.70354},
  url = {https://doi.org/10.1111/cbdd.70354}
}

RIS

TY  - JOUR
TI  - In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.
AU  - Romano A
AU  - Buccheri R
AU  - Zagni C
AU  - Rescifina A
PY  - 2026
JO  - Chemical biology & drug design
DO  - 10.1111/cbdd.70354
UR  - https://doi.org/10.1111/cbdd.70354
ER  - 

APA

A, R., R, B., C, Z., & A, R. (2026). In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.. Chemical biology & drug design. https://doi.org/10.1111/cbdd.70354

Source records